{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:49:25Z","timestamp":1740160165166,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T00:00:00Z","timestamp":1515715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s13300-017-0360-6","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T11:30:52Z","timestamp":1515756652000},"page":"309-315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Characteristics of Elderly Patients Initiating Sitagliptin or Non-DPP-4-Inhibitor Oral Antihyperglycemic Agents: Analysis of a Cross-Sectional US Claims Database"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7621-7781","authenticated-orcid":false,"given":"Tongtong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann Marie","family":"McNeill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward A.","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel S.","family":"Engel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,12]]},"reference":[{"key":"360_CR1","volume-title":"IDF diabetes","author":"International Diabetes Federation","year":"2015","unstructured":"International Diabetes Federation. IDF diabetes. 7th ed. Brussels: International Diabetes Federation; 2015.","edition":"7"},{"key":"360_CR2","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.2337\/dc12-1801","volume":"35","author":"MS Kirkman","year":"2012","unstructured":"Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, et al. Diabetes in older adults. Diabetes Care. 2012;35:2650\u201364.","journal-title":"Diabetes Care"},{"key":"360_CR3","volume-title":"National diabetes fact sheet: general information and national estimates on diabetes in the United States","author":"Centers for Diabetes Control and Prevention","year":"2011","unstructured":"Centers for Diabetes Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States. Atlanta: US Department of Health and Human Services Centers for Disease Control and Prevention; 2011."},{"key":"360_CR4","unstructured":"Statistical analysis by the Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Diabetes Translation (2011). http:\/\/diabetes.niddk.nih.gov\/dm\/pubs\/statistics\/ ."},{"key":"360_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s11606-010-1510-y","volume":"26","author":"CT Cigolle","year":"2011","unstructured":"Cigolle CT, Lee PG, Langa KM, Lee YY, Tian Z, Blaum CS. Geriatric conditions develop in middle-aged adults with diabetes. J Gen Intern Med. 2011;26:272\u20139.","journal-title":"J Gen Intern Med"},{"key":"360_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2337\/dc14-2441","volume":"38","author":"SE Inzucchi","year":"2015","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38:140\u20139.","journal-title":"Diabetes Care"},{"key":"360_CR7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/sim.4780100409","volume":"10","author":"H Petri","year":"1991","unstructured":"Petri H, Urquhart J. Channeling bias in the interpretation of drug effects. Stat Med. 1991;10:577\u201381.","journal-title":"Stat Med"},{"key":"360_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2174\/156802607780091028","volume":"7","author":"NA Thornberry","year":"2007","unstructured":"Thornberry NA, Weber AE. Discovery of JANUVIA (Sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Curr Top Med Chem. 2007;7:557\u201368.","journal-title":"Curr Top Med Chem"},{"key":"360_CR9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1056\/NEJMoa1501352","volume":"373","author":"JB Green","year":"2015","unstructured":"Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, et al. Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015;373:232\u201342.","journal-title":"N Engl J Med"},{"key":"360_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1475-2840-12-3","volume":"12","author":"SS Engel","year":"2013","unstructured":"Engel SS, Golm GT, Shapiro D, Davies MJ, Kaufman KD, Goldstein BJ. Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis. Cardiovasc Diabetol. 2013;12:3.","journal-title":"Cardiovasc Diabetol"},{"key":"360_CR11","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/j.1742-1241.2010.02382.x","volume":"64","author":"SS Engel","year":"2010","unstructured":"Engel SS, Williams-Herman DE, Golm GT, Clay RJ, Machotka SV, Kaufman KD, et al. Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis. Int J Clin Pract. 2010;64:984\u201390.","journal-title":"Int J Clin Pract"},{"key":"360_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s13300-013-0024-0","volume":"4","author":"SS Engel","year":"2013","unstructured":"Engel SS, Round E, Golm GT, Kaufman KD, Goldstein BJ. Safety and tolerability of sitagliptin in type 2 diabetes: pooled analysis of 25 clinical studies. Diabetes Ther. 2013;4:119\u201345.","journal-title":"Diabetes Ther"},{"key":"360_CR13","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1111\/j.1742-1241.2010.02516.x","volume":"64","author":"B Cai","year":"2010","unstructured":"Cai B, Katz L, Alexander CM, Williams-Herman D, Girman CJ. Characteristics of patients prescribed sitagliptin and other oral antihyperglycaemic agents in a large US claims database. Int J Clin Pract. 2010;64:1601\u20138.","journal-title":"Int J Clin Pract"},{"key":"360_CR14","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1185\/03007995.2010.489029","volume":"26","author":"Q Zhang","year":"2010","unstructured":"Zhang Q, Rajagopalan S, Mavros P, Engel SS, Davies MJ, Yin D, et al. Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database. Curr Med Res Opin. 2010;26:1697\u2013703.","journal-title":"Curr Med Res Opin"},{"key":"360_CR15","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s13300-015-0133-z","volume":"6","author":"KG Brodovicz","year":"2015","unstructured":"Brodovicz KG, Chen Y, Liu Z, Ritchey ME, Liao J, Engel SS. Characterization of sitagliptin use in patients with Type 2 diabetes and chronic kidney disease by cross-sectional analysis of a medical insurance claims database. Diabetes Ther. 2015;6:627\u201334.","journal-title":"Diabetes Ther"},{"key":"360_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/ijcp.12090","volume":"67","author":"KG Brodovicz","year":"2013","unstructured":"Brodovicz KG, Kou TD, Alexander CM, O\u2019Neill EA, Senderak M, Engel SS, et al. Recent trends in the characteristics of patients prescribed sitagliptin and other oral antihyperglycaemic agents in a large US claims database. Int J Clin Pract. 2013;67:449\u201354.","journal-title":"Int J Clin Pract"},{"key":"360_CR17","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28:3083\u2013107.","journal-title":"Stat Med"},{"key":"360_CR18","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/pds.3574","volume":"23","author":"MS Ali","year":"2014","unstructured":"Ali MS, Groenwold RH, Pestman WR, Belitser SV, Roes KC, Hoes AW, et al. Propensity score balance measures in pharmacoepidemiology: a simulation study. Pharmacoepidemiol Drug Saf. 2014;23:802\u201311.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-017-0360-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13300-017-0360-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-017-0360-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T13:09:25Z","timestamp":1719752965000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13300-017-0360-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,12]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["360"],"URL":"https:\/\/doi.org\/10.1007\/s13300-017-0360-6","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"type":"print","value":"1869-6953"},{"type":"electronic","value":"1869-6961"}],"subject":[],"published":{"date-parts":[[2018,1,12]]},"assertion":[{"value":"30 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}